Lepirudin in patients with heparin-induced thrombocytopenia – results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3
- 1 November 2005
- journal article
- clinical trial
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 3 (11) , 2428-2436
- https://doi.org/10.1111/j.1538-7836.2005.01623.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studiesBlood, 2004
- Heparin-Induced Thrombocytopenia: Recognition, Treatment, and PreventionChest, 2004
- Treatment of Heparin-Induced ThrombocytopeniaArchives of internal medicine (1960), 2004
- Anaphylactic and Anaphylactoid Reactions Associated With Lepirudin in Patients With Heparin-Induced ThrombocytopeniaCirculation, 2003
- Argatroban Anticoagulation in Patients With Heparin-Induced ThrombocytopeniaArchives of internal medicine (1960), 2003
- Recombinant Hirudin in Clinical PracticeCirculation, 2001
- Lepirudin (Recombinant Hirudin) for Parenteral Anticoagulation in Patients With Heparin-Induced ThrombocytopeniaCirculation, 1999
- Recombinant Hirudin (Lepirudin) Provides Safe and Effective Anticoagulation in Patients With Heparin-Induced ThrombocytopeniaCirculation, 1999
- The development of hirudin as an antithrombotic drugThrombosis Research, 1994
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990